Cargando...
HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
The use of high dose posttransplant cyclophosphamide (PT-CY) introduced by the Baltimore group approximately 10 years ago has been rapidly adopted worldwide and is becoming a standard for patients undergoing unmanipulated haploidentical (HAPLO) transplants. PT-CY has been used following nonmyeloabla...
Guardado en:
| Publicado en: | Adv Hematol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Hindawi Publishing Corporation
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4838781/ https://ncbi.nlm.nih.gov/pubmed/27143973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/7802967 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|